A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)

NCT01527383 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

354

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: V212
BIOLOGICAL: Placebo

Sponsor

Merck Sharp & Dohme LLC